
Span40 mg
Opsonin Pharma Ltd.
Drotaverine is indicated for the symptomatic relief of smooth muscle spasm.
Drotaverine is indicated for the symptomatic relief of smooth muscle spasm. Evidence and regulatory support vary by indication:
Drotaverine relieves spasm-related pain symptomatically but does not treat the underlying cause; a physician should evaluate persistent, severe, or atypical pain.
Dosing of Drotaverine should be individualized based on indication, severity of symptoms, and route of administration.
| Indication | Adult Dose | Route |
|---|---|---|
| GI spasm, biliary colic, IBS-related spasm | 40-80 mg, 2-3 times daily (max 240 mg/day) | Oral |
| Renal colic (acute) | 40-80 mg | Slow IV or IM injection, may repeat as directed by physician |
| Dysmenorrhea | 40-80 mg, 1-3 times daily as needed during symptomatic days | Oral |
| Adjunct in labor (cervical dilation) | As determined by attending obstetrician; not standardized | Oral or IM, under direct medical supervision only |
Pediatric dose: See Use in Special Populations.
Renal/hepatic impairment: Use with caution and at the lower end of the dosing range in patients with hepatic or renal impairment; avoid in severe hepatic, renal, or cardiac failure (see Contraindications).
Drotaverine is generally well tolerated at recommended doses. Reported side effects include:
Drotaverine is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.